Sulfamethoxazole
Back to searchMolecule Structure
Scientific Name
Sulfamethoxazole
Description of the Drug
Sulfamethoxazole is an oral sulfonamide antibiotic, given in combination with trimethoprim, used to treat a variety of infections of the urinary tract, respiratory system, and gastrointestinal tract.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01015
http://www.drugbank.ca/drugs/DB01015
Brand Name(s)
Acetylsulfamethoxazole, Gantanol, Gantanol-ds, Sinomin, Sulfamethoxazole, Suphamethoxazole, Urobak
Company Owner(s)
Sun Pharmaceutical Industries Inc, Watson Laboratories Inc, Ascot Hosp Pharmaceuticals Inc Div Travenol Laboratories Inc, Novitium Pharma Llc, Able Laboratories Inc, Prasco Llc Dba Prasco Laboratories, Bedford Laboratories Div Ben Venue Laboratories Inc, Rising Pharma Holdings Inc, Akorn Operating Co Llc, Teva Pharmaceuticals Usa Inc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Bacterial dihydropteroate synthase | SINGLE PROTEIN | INHIBITOR | CHEMBL2364668 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL3656 | |
PharmGKB | PA451544 | |
Human Metabolome Database | HMDB0015150 | |
DrugBank | DB01015 | |
PubChem: Thomson Pharma | 14798729 | |
PubChem | 5329 | |
Mcule | MCULE-1450176600 | |
NMRShiftDB | 20208059 | |
LINCS | LSM-5422 | |
Nikkaji | J4.525J | |
PDBe | 08D | |
BindingDB | 50029770 | |
EPA CompTox Dashboard | DTXSID8026064 | |
DrugCentral | 2514 | |
Brenda | 50294 | 2097 |
ChemicalBook | CB6473303 | |
Guide to Pharmacology | 10933 | |
rxnorm | SULFAMETHOXAZOLE | |
KEGG Ligand | C07315 | |
ChEBI | 9332 | |
ZINC | ZINC000000089763 |